Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;62(8):2689-98.
doi: 10.2337/db12-0754. Epub 2013 Feb 4.

Metabolite profiles during oral glucose challenge

Affiliations

Metabolite profiles during oral glucose challenge

Jennifer E Ho et al. Diabetes. 2013 Aug.

Abstract

To identify distinct biological pathways of glucose metabolism, we conducted a systematic evaluation of biochemical changes after an oral glucose tolerance test (OGTT) in a community-based population. Metabolic profiling was performed on 377 nondiabetic Framingham Offspring cohort participants (mean age 57 years, 42% women, BMI 30 kg/m(2)) before and after OGTT. Changes in metabolite levels were evaluated with paired Student t tests, cluster-based analyses, and multivariable linear regression to examine differences associated with insulin resistance. Of 110 metabolites tested, 91 significantly changed with OGTT (P ≤ 0.0005 for all). Amino acids, β-hydroxybutyrate, and tricarboxylic acid cycle intermediates decreased after OGTT, and glycolysis products increased, consistent with physiological insulin actions. Other pathways affected by OGTT included decreases in serotonin derivatives, urea cycle metabolites, and B vitamins. We also observed an increase in conjugated, and a decrease in unconjugated, bile acids. Changes in β-hydroxybutyrate, isoleucine, lactate, and pyridoxate were blunted in those with insulin resistance. Our findings demonstrate changes in 91 metabolites representing distinct biological pathways that are perturbed in response to an OGTT. We also identify metabolite responses that distinguish individuals with and without insulin resistance. These findings suggest that unique metabolic phenotypes can be unmasked by OGTT in the prediabetic state.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Heat map of correlated metabolite changes with glucose challenge.
FIG. 2.
FIG. 2.
Metabolite excursions after glucose challenge in metabolic pathways that reflect the effects of insulin. Notable perturbations include decreased proteolysis (as evidenced by lower amino acids and amino acid metabolites), inhibition of ketogenesis (lower β-hydroxybutyrate), suppression of the TCA cycle, and activation of glycolysis. % change = 100 × (up-fold change – 1) or 100 × (1 − down-fold change).
FIG. 3.
FIG. 3.
Metabolite excursions after glucose challenge in pathways that are not previously established in relation to glucose or insulin metabolism. Notable perturbations include inhibition of the serotonin system, decrease in metabolites of the urea cycle, suppression of nucleic acids, decrease in all vitamins of the B superfamily, increase in all conjugated bile acids, and decrease in deconjugated bile acids. % change = 100 × (up-fold change – 1) or 100 × (1 − down-fold change).
FIG. 4.
FIG. 4.
Metabolite excursions after glucose challenge in participants with and without insulin resistance. Analyses are adjusted for age, sex, and BMI. Error bars represent 95% CIs. Changes for ketogenesis (β-hydroxybutyrate), proteolysis (isoleucine), and glycolysis (lactate) are all blunted in insulin-resistant individuals.

Comment in

References

    1. Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
    1. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373:2215–2221 - PMC - PubMed
    1. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448–453 - PMC - PubMed
    1. Rhee EP, Cheng S, Larson MG, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011;121:1402–1411 - PMC - PubMed
    1. Tuomilehto J, Lindström J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–1350 - PubMed

Publication types